Abstract
Introduction
Transdermal drug delivery is perhaps one of the most successful controlled release technologies available today (Guy, 1996) . Nevertheless, to efficiently overcome the barrier function of the skin often remains a problem. Besides the stratum corneum, representing a major physical barrier, the skin behaves also as an efficient metabolic barrier capable of degrading a wide variety of compounds (Kao and Carver, 1990; . Therefore, first-pass-type cutaneous metabolism can be a significant source of presystemic clearance of xenobiotics. For example, in rhesus monkeys cutaneous metabolism accounts for a ~20% loss in systemic bioavailability of transdermally administered nitroglycerin (Wester et al, 1983) , and leads to a complete cutaneous cleavage of buprenorphine prodrugs (Stinchcomb et al, 1996) .
Physical modeling is a tool to understand the kinetics of metabolic processes in living tissue and to evaluate factors effecting metabolism and related mass transport.
Because diffusion and metabolism in viable tissues are mechanistically connected (Potts et al, 1989; , the flux of intact substrate permeating a metabolizing tissue will be influenced by both mass transport and metabolism parameters. Physical models have been described in the literature to explain the interplay between mass transport and concurrent metabolism and to analyze the experimental data. Usually they are based on Fickian diffusion in combination with first order metabolic reactions (e.g. Yu et al, 1979a , Tojo et al, 1985 , Sato and Mine, 1996 . While the assumption of first order metabolism kinetics may hold for low drug concentrations (Higuchi et al, 1983) , non-linear saturation kinetics is more typical for high drug concentrations or low enzyme contents in the skin (Schäfer and Redelmeier, 1996; Sugibayashi et al, 1996) . In those cases, saturable Michaelis-Menten kinetics, in combination with Fickian diffusion, is more appropriate to describe cutaneous metabolism.
Previously, we proposed a physical model for the quantitative interpretation of steady state mass transport and concurrent metabolism in metabolically active cell sheets under reflection kinetics, i.e. with an impermeable wall on one side of the tissue resulting in reflection of both substrate and metabolite fluxes . The model was based on Fickian diffusion in combination with saturable Michaelis-Menten kinetics to account for the metabolic cleavage. The study was run in cultured HaCaT cell sheets, a human transformed keratinocyte cell line. In a practically more relevant study we extended this work to permeation kinetics in cultured HaCaT cell sheets versus stripped human skin. Both data sets could be correlated on the basis of a uniform physical model (Boderke et al, in press) . A related physical model including the stratum corneum as a second compartment was previously introduced to analyze mass transport and metabolism of ethyl nicotinate in hairless rat skin (Sugibayashi et al, 1996) .
Here, we will illustrate the influence of various mass transport and metabolism parameters (i.e. diffusion coefficient D, tissue thickness L, partition coefficient P and maximum metabolic rate V max ) on the concentration gradients across metabolizing tissue. In order to validate the underlying theory we will compare numerically generated data with experimental data on the permeation of a peptidomimetic compound through HaCaT cell culture sheets and strippend human skin. Also we present the corresponding fluxes of intact substrate which will be delivered through the tissue as a function of donor substrate concentration.
Theoretical
The physical model. Consider a layer 0 ≤ x ≤ L of metabolizing tissue of the thickness L. At the position x = 0, i.e. the donor/tissue interface, the layer is in contact with a well stirred donor solution of a defined substrate concentration C S,D . At the position x = L, the tissue/receiver interface, the tissue is in contact with a well stirred receiver solution. Substrate partitions into the tissue according to its partition coefficient P and passes the layer by passive diffusion. Upon passage of the metabolizing tissue degradation of substrate S to metabolite M occurs. Based on the concentration gradient the generated metabolite will diffuse into both the donor and the receiver compartment. A schematic representation of the proposed model is given in Fig 1. The following assumptions were made:
• Metabolism occurs in the tissue only, and is assumed to follow Michaelis-Menten kinetics.
• For simplicity only, the distribution of the metabolically active enzymes in the layer is assumed to be homogeneous.
• Mass transport is one-dimensional and restricted to the x coordinate Changes in the concentration of substrate C S and metabolite C M in the tissue as a function of time t and distance x are given by the following set of partial differential equations of parabolic type:
where D S and D M are the effective diffusion coefficients of substrate and metabolite in the tissue, respectively, and V max and K m are the maximum metabolic rate and the Michaelis constant, respectively.
If no enzymatic activity is present, i.e. V max = 0, only passive diffusion of the substrate occurs and the equations simplify to:
Under steady state conditions the changes in substrate and metabolite concentration with time are zero, therefore:
The tissue is initially considered to be free of drug and metabolite, thus the initial conditions are:
Assuming that drug and metabolite concentrations in the receiver as well as the metabolite concentration in the donor are zero (perfect sink conditions) boundary conditions were set as follows:
Substrate concentration at x = 0 is equal to the substrate concentration in the donor compartment C S,D , corrected by the apparent tissue/buffer partition coefficient P:
Under infinite dose conditions this concentration is assumed to be constant.
Alternatively we may assume a time dependent decrease of substrate concentration in the donor due to the permeation of substrate. Such finite dose conditions can be modeled by coupled ordinary differential equations. The amount Q of substrate S permeating from the donor through an area A into the tissue is described by:
The coupling to the partial differential equation is obtained by defining the new boundary condition in the form:
where V D denotes the volume of the donor solution.
Likewise the cumulative amount Q of substrate and metabolite which permeates through an area A into the donor and receiver compartment, respectively, can be obtained by the following equations:
These cumulative amounts can be evaluated numerically and compared with experimental data. Concentration gradients of substrate and metabolite at each position x within the skin at the time t can be numerically generated from equations 1 and 2.
The gradients at the interfaces will determine fluxes of substrate and metabolite: ) corresponding to data previously published by Yu et al (1979b) and Sugibayashi et al (1996) (Schittkowski, 1996) , that allows to identify parameters in dynamic systems, especially in systems of one-dimensional, time-dependent partial differential equations with coupled ordinary differential equations. Starting from given experimental data, i.e. substrate and metabolite concentrations in donor and receiver for various observation times, the minimum least squares distance of measured values from a fitting criterion is computed, that depends on the solution of the dynamical system. For the numerical integration and parameter identification, the Fortran code PDEFIT is executed by the user interface (Schittkowski, 1997 ).
Basically we need to minimize 
where r measurement sets and p measurements per set are available. The model function h k (p,t) depends on the parameter vector p, the time variable t, but also on the solution of the underlying partial differential equation and corresponding coupled ordinary differential equations, as discussed before.
The underlying idea is to transform the set of partial differential equations into a system of ordinary differential equations by discretizing the model functions with respect to the spatial variable x. This approach is known as the method of lines (Schiesser 1991) . The integration interval is divided into equidistant grid points and first and second partial derivatives of C S (x,t) and C M (x,t) with respect to the spatial variable x are computed by a polynomial interpolation subject to the neighboring values. The number of interpolation points depends on the polynomial degree selected, i.e. the desired final accuracy. The resulting large system of ordinary differential equations is then solved by an implicit Runge-Kutta method of order 5 (Hairer and Wanner, 1991) , since these equations tend to become stiff with increasing discretization accuracy.
Finally the resulting nonlinear least squares problem is solved by the code DFNLP (Schittkowski, 1988) , a combination of Gauss-Newton and quasi-Newton method for constrained problems. The algorithm requires first derivatives with respect to the parameters to be estimated, which are approximated by forward differences.
Experimental
Materials. Alanine-4-methoxy-2-naphthylamide (Ala-MNA) and its metabolite 4-methoxy-2-naphthylamine (MNA) were purchased from Sigma Chemical Company glucose, warmed to 37°C, constantly stirred and gassed with prehumidified oxygen.
To initiate the experiment, 100 µl donor solution was replaced by 100 µl of Ala-MNA stock solution to obtain initial donor substrate concentrations of 20-500 nmol ml
Samples of 100 µl were periodically withdrawn from donor and receiver and replaced with fresh buffer. Samples were analyzed by HPLC for substrate and metabolite as previously described (Steinsträsser et al, 1997) . All experiments were run at least in triplicate. 
Results and Discussion
The ) the substrate concentration drops steeply with increasing distance. Consequently, due to its rate-limiting function, diffusion restricts the access of fresh substrate to the tissue. Therefore, most of the substrate will be metabolized in the upper tissue layers, with no intact substrate reaching layers furthest from the surface. Thus, only metabolite arrives in the receiver compartment (or the systemic circulation).
Fluxes of substrate into the receiver compartment relative to the donor substrate concentration are also illustrated (Fig 2b) . This depicts the potential for the substrate to reach the systemic circulation. ) the concentration gradients at the tissue/receiver interface are practically zero (Fig 2a) , all of the substrate will be metabolized in the top layers of the tissue and no measurable flux of substrate into the receiver occurs (Fig 2b) .
Since the diffusion coefficient is related to the molecular volume of a molecule (Kasting et al, 1987) , labile substrates of high molecular weight with a correspondingly low diffusion coefficient may have little chance to pass the metabolizing tissue under passive diffusion. the drug is metabolized on its way through the epidermis. Therefore, no flux of intact substrate into the receiver is observed. Metabolism becomes negligible for high partition coefficients, therefore substrate flux into the receiver is roughly proportional to the substrate concentration in the donor (Fig 2d) . Physically, the layer can be (Davis and Hadgraft, 1991) .
Maximum metabolic rate V max . The parameter V max combines the concentration of metabolic enzyme present and how readily it catalyzes the reaction (London and Shaw, 1983) . Increases in the maximum metabolic rate result in steeper substrate concentration gradients within the tissue (Fig 2e) and, thus, in reduced substrate flux into the receiver (Fig 2f) . The effect is similar to that observed before with the diffusion coefficient.
As expected a linear relation of substrate concentration versus distance within the tissue is observed when V max is zero (Fig 2e) . Correspondingly, under such conditions substrate flux into the receiver is proportional to the donor concentration as described by equation 3 (Fig 2f) . For medium values of V max a nonlinear relationship of the flux versus substrate concentration plot is obtained. This is explained by partial saturation of the enzymatic reaction at higher substrate concentrations. At the highest value selected the flux of intact substrate into the receiver is practically zero.
Obviously, depending on the extent of metabolic activity, the flux of drug delivered to the receiver is partially or fully reduced. Thus, for drugs susceptible to enzymatic cleavage, simultaneous delivery of a suitable enzyme inhibitor, e.g. by transdermal iontophoresis, may be a means to increase drug bioavailability. As seen in the simulations before, increases in substrate concentrations will somewhat limit the relative extent of metabolism by saturation of the enzyme. (Fig 3c) . Therefore, metabolically highly labile substrates are difficult to deliver transdermally by passive diffusion alone.
The corresponding dimensionless metabolite concentration profiles for the various tissue thickness are illustrated in Fig 3b. With increasing tissue thickness the peak metabolite concentration increases and shifts towards the donor side. In 100 µm thick cell sheets all of the substrate will be degraded to its metabolite within the first ~20 µm (Fig 3a) . In the remainder of the tissue no more metabolite is generated and the transport of the metabolite is only subject to passive diffusion, resulting in a linear metabolite concentration gradient with increasing relative distance x/L (Fig 3b) .
Prediction of experimental data
In this theoretical analysis of simultaneous mass transport and metabolism in living tissue several assumptions were made. Assuming constant diffusivity throughout the tissue was for the sake of simplicity. Parallel to the morphological differences in polarized tissue, e.g. in the viable epidermis or in HaCaT cell sheets, also differences in diffusivities may be expected. Thus, the effective tissue diffusion coefficient will be a weighed average of the diffusivities in the various regions and routes (e.g. transcellular versus paracellular). Also the assumption of homogeneous enzyme distribution across the tissue was for the sake of simplicity only. Indeed, by confocal microscopy we recently visualized that aminopeptidase activity was more or less evenly distributed in the viable epidermis of human skin except for so called 'hot spots' with enhanced enzyme activity, which were specifically found towards the stratum corneum (Boderke et al, 1997) . Such regional differences in enzymatic activity can be implemented in a physical model but increase the complexity of the system. For the model calculations here, we assume even distribution of aminopeptidase activity as a first approximation.
To verify the physical model with its assumptions and to test its ability to predict experimental results, permeation experiments with HaCaT cell sheets and freshly excised stripped human skin were performed. HaCaT is a spontaneously transformed human keratinocyte cell line, preserving some of the morphological and biochemical features of normal human keratinocytes (Boukamp et al, 1988; Ryle et al, 1989) . Based on this background, HaCaT cell cultures may serve as a model for the viable epidermis (Boderke et al, in press) . Permeation experiments with the peptidomimetic model drug Ala-4-methoxy-2-naphthylamide (Ala-MNA), a substrate for aminopeptidases, were performed at different initial substrate concentrations and compared to simulated data.
A fixed set of independently obtained mass transport and metabolism parameters was used for these simulations as described in the theoretical section.
A typical set of permeation data for an initial Ala-MNA donor concentration of ~500 nmol ml For example, the partition coefficient P applied was derived from octanol/water partitioning experiments. Biological partitioning of Ala-MNA may be different, but is experimentally not accessible. 
Parameter estimation by least squares fit
The parameter estimation algorithm PDEFIT (Schittkowski, 1997) was used for least squares fits of the permeation data set (HaCaT sheets and stripped skin) given in Previously, good agreement of simulations and experimental data was also demonstrated for the diffusion and concurrent metabolism of Ala-MNA under reflection conditions , for the permeation of Ala-MNA through HaCaT sheets and stripped human skin (Boderke et al, in press ) and for the simultaneous transport and metabolism of ethyl nicotinate in full thickness hairless rat skin (Sugibayashi et al, 1996) . This supports the validity of the physical model.
However, further studies involving additional substrates of various physical and chemical properties are needed to demonstrate the general applicability of the physical model.
Physical relations between mass transport and metabolism parameters
As indicated in equation 14 and 15 the concentration gradients at the donor/tissue interface and at the tissue/receiver interface determine the fluxes of substrate into the tissue and out of the tissue, respectively. With the details of the derivations given in the Appendix, the relationship between the parameters L, D, P, K m and V max and the differences of the squares of the concentration gradients at these two interfaces is given by:
and by introducing the coefficients 2α and β: (Ho, 1993) . The longer a substrate is in contact with metabolizing enzymes, the greater the total extent of metabolism. Since the residence time term is proportional to L 2 , the impact of tissue thickness is greater than that of the diffusion coefficient. In other words, with respect to the concentration gradients, a 10-fold increase in distance L is equivalent to a 100-fold decrease of D or a 100-fold increase of V max , respectively.
On the other hand, the term C S,D P / 2V max may represent the metabolic half-life of the substrate under zero order kinetics (i.e. at saturation), with V max being the maximum metabolic rate. Therefore, the dimensionless coefficient 2α =
is the ratio of the residence time term and the metabolic half-life term, and represents a relative quantity to describe the extent of metabolism. If the residence time term is small relative to the metabolic half-life term, small values for the coefficient 2α will result, and the chance for intact substrate molecules to permeate the tissue is high. On the contrary, when a large residence time term outweighs the metabolic half-life term, 2α is high and permeation of intact substrate is blocked by efficient metabolism.
L is a key parameter for the kinetics of mass transport and concurrent metabolism as it has a quadratic impact on 2α. Whereas diffusion through thin layers (e.g. HaCaT The results illustrate the efficient barrier function of the skin for metabolically labile drugs. For buccal drug delivery the metabolizing tissue is even thicker (~300-500 µm), lowering the chance for intact substrate permeating through buccal tissue, assuming, that all the other parameters are similar. In fact, as shown by Garren et al (1989) for the in vitro permeation of Leu-p-nitroanilide across excised buccal hamster cheek pouch epithelium, complete metabolization of the substrate was observed. Vice versa, the ability of a tissue to metabolize xenobiotics represents an important feature for prodrug approaches and for dermal toxicity considerations. Therefore, the proposed model may be also helpful for the development of prodrugs and to evaluate the toxicity of skin pollutants.
In conclusion, our studies demonstrate a quantitative framework to model diffusion and cutaneous metabolism for dermal and transdermal delivery. respectively. Standard parameter estimates were used for all simulations as indicated in Table 1 . Table 1 . was chosen for all steady-state simulations. 
